SourcingAI
Try for free
Powered by Made-in-China.com
Enoxaparin Sodium Injection Prefilled Syringe Ih, USP
US$2.60-3.10
10,000 Vial

Product profile

Application

Internal Medicine

Usage Mode

Ih

Suitable for

Elderly, Adult

Model NO.

0.4ml and 0.6ml

State

Liquid

Shape

Injection

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Ingredient

Enoxaparin Sodium

Standard

USP

Transport Package

Prefilled Syringe in Box and Carton

Specification

0.4ml: 4000AxaIU and 0.6ml: 6000AxaIU

Origin

P. R. China

HS Code

3004909099

Production Capacity

10 Million Vials/Year

Key features

Proven DVT Prophylaxis: Indicated for preventing deep vein thrombosis in abdominal, hip, and knee surgery patients.
Acute DVT Treatment: Effective for inpatient and outpatient treatment of acute deep vein thrombosis with or without PE.
Unstable Angina Protection: Reduces ischemic complications when used with aspirin for unstable angina and non-Q-wave MI.
STEMI Outcome Improvement: Reduces recurrent MI or death in STEMI patients receiving thrombolysis with aspirin.
USP Standard Quality: Manufactured with Enoxaparin Sodium meeting strict United States Pharmacopeia standards.
Ready-to-Use Syringe: Pre-filled syringe format designed for convenient internal medicine administration.
Broad Patient Suitability: Suitable for elderly and adult patients requiring thromboembolic risk management.
Flexible Payment Options: Accepts LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

Company profile

Beijing DC-Pharma Co., Ltd.
Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersMulti-language Pioneer
Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2022-03-25Average Response Time: >24hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB

About Our Factory & Business Background

AddressRoom No. 217, Second Floor, Wangjing Street, Chaoyang Dist, Beijing, china
Average Lead TimePeak Season Lead Time: 1-3 months Off Season Lead Time: 1-3 months

Our Production Capability & Technical Expertise

Main ProductsInjections, Ampoules, Tablets, Capsules, Powder

Our Industry Experience & Global Business Record

Main MarketsEastern Europe, Southeast Asia, Mid East

Product Q&A

Q:What is the primary indication for Enoxaparin Sodium Injection?
A:
It is indicated for the prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE) in surgical and medical patients, as well as for treating acute DVT and unstable angina.
Q:Who is this medication suitable for?
A:
The product is suitable for elderly and adult patients undergoing abdominal, hip, or knee replacement surgery, or those with restricted mobility due to acute illness.
Q:What is the standard of the active ingredient?
A:
The active ingredient, Enoxaparin Sodium, meets the USP (United States Pharmacopeia) standard.
Q:How is the product administered?
A:
It is a liquid injection in a pre-filled syringe format, intended for internal medicine use.
Q:What are the lead times for this product?
A:
The average lead time is 1-3 months for both peak season and off-season periods.

Send Inquiry

*To:Beijing DC-Pharma Co., Ltd.Beijing DC-Pharma Co., Ltd.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like

Mining Reagent Sodium Sulfite From China

Mining Reagent Sodium Sulfite From China

US$2,500.00-2,700.00
1 Ton(MOQ)
Made-in-China.com